Introduction
============

Diabetes mellitus (DM) is the oldest disease known to mankind since about 3,000 years ago and is referred to in ancient Egyptian treatise.[@b1-dddt-11-1567] The prevalence of DM is continuously increasing and recent estimate shows that DM incidence will rise from 366.2 million people to 551.8 million by 2030.[@b2-dddt-11-1567],[@b3-dddt-11-1567] Generally, DM is classified as either Type-I or II, but Type-II DM is more prevalent form of diabetes. The long-term macrovascular and microvascular complications associated with Type-II DM typically ends up in morbidity and mortality. Type-II DM has a complex and multifactorial pathogenesis. It occurs either due to impaired insulin secretion by pancreas or development of insulin resistance at target tissues. Insulin maintains the energy homeostasis by increasing glucose uptake into peripheral tissues and decreasing release of stored lipids from adipose tissue.[@b4-dddt-11-1567] Dysfunction of β-cell decreases insulin secretion and alters the glucose homeostasis.[@b5-dddt-11-1567] Multiple biochemical pathways show the correlation between hyperglycemia and vascular complications. Type-II DM has a role in the development of cardiovascular and kidney diseases.[@b6-dddt-11-1567]--[@b8-dddt-11-1567] Type-II DM is manifested by increased glucose production, defective insulin secretion and abnormal insulin action.[@b9-dddt-11-1567],[@b10-dddt-11-1567] The β-cell associated changes in the secretion of insulin initiates the cellular signaling cascade. Activation of advanced glycation end products, stimulation of Di-acyl glycerol kinase pathway and oxidative stress reduces the β-cell functioning.

The currently available anti-diabetic drugs used to treat Type-II DM are associated with potential adverse effects.[@b11-dddt-11-1567],[@b12-dddt-11-1567] Excessive insulin release by widely used anti-diabetic drugs like sulfonylureas causes hypoglycemia.[@b13-dddt-11-1567] Similarly, use of peroxisome proliferator-activated receptor (PPAR-γ) agonists is associated with weight gain, fluid retention, urinary bladder cancer, osteoporosis and cardiovascular complications.[@b14-dddt-11-1567] Rosiglitazone is PPAR agonist and widely used anti-diabetic drug. It acts primarily through the activation of AMP-activated protein kinase (AMPK) and its use is associated with weight gain and edema. Similarly, the antidiabetic effect of metformin exhibits the partial involvement of AMPK and shows the associated adversities. Despite promising preclinical results, the drug 5-Aminoimidazole-4-carboxamide nucleotide failed to demonstrate its efficacy in phase I clinical trial. Due to safety concerns, many promising molecules like dual-acting PPAR γ/α or pan modulators of PPAR are still awaiting the US Food and Drug Administration (FDA) approval. Remedial approaches for the management of Type-II DM are aimed to delay the onset of complications following treatment with antidiabetic drugs. The search for more efficacious and safer antidiabetic agents is an active area of research. Newer drugs lacking the adverse effects of conventional antidiabetics and having ability to control hyperglycemia are critically needed. Incidence of Type-II DM can be minimized by identification of risk factors responsible for its occurrence. Understanding of mechanisms of actions of antidiabetic drugs, signaling pathways and therapeutic targets of Type-II DM can guide the development of clinically useful antidiabetic drugs. Present review provides an overview of underlying mechanisms of action of antidiabetic drugs. This paper also contains information on promising therapeutic targets of Type-II DM evolved from pharmacological and molecular studies.

Promising therapeutic targets
-----------------------------

The treatment of Type-II DM and management of diabetic complications is a complex area of therapy. Limited treatment opportunities and shortage of therapeutic agents used to delay the diabetic complications are main hurdles in the treatment of Type-II DM. This therapeutic mystery can be resolved by the identification of novel therapeutic targets and development of new drugs. Postprandial euglycemia is maintained by gut-derived peptide hormones (incretins), glucagon-like peptide-1 (GLP-1) (neuropeptide) and gastric inhibitory polypeptide/glucose-dependent insulinotropic peptide (GIP) through the stimulation of insulin secretion. Dipeptidyl peptidase-IV (DPP-IV) is a protease enzyme responsible for degradation of incretins. Inhibition of DPP-IV prevents the degradation of incretins, GLP-1 and GIP. It leads to elevated lowering of blood glucose level and control of hyperglycemia.[@b15-dddt-11-1567] Alogliptin is selective DPP-IV inhibitor approved by FDA for the treatment of Type-II DM in 2013. Development of insulin resistance in humans and rodents is a consequence of abnormal or overexpressed glycogen synthase kinase 3 (GSK-3). Two isozymes of GSK-3 that is, GSK-3α and GSK-3β are present in mammals. GSK-3β-2 is an alternative splice variant of GSK-3β.[@b16-dddt-11-1567] Although, GSK-3α and GSK-3β have close similarity in their catalytic domains, they differ at their N- and C-terminal regions.[@b17-dddt-11-1567] Selective GSK-3 inhibitors demonstrated their efficacy in animal models of Type-II DM through the increased insulin action in insulin-resistant skeletal muscle.[@b18-dddt-11-1567] Identification and understanding of therapeutic targets in Type-II DM is essential for the designing of therapeutic strategy. Various therapeutic targets in Type-II DM are summarized in [Tables 1](#t1-dddt-11-1567){ref-type="table"} and [2](#t2-dddt-11-1567){ref-type="table"}.

SIRT-1: insulin resistance and insulin availability
---------------------------------------------------

SIRT-1 refers to sirtuin (silent mating type information regulation 2 homolog)-1. It is a member of sirtuin protein family known as nicotinamide adenine dinucleotide (NAD) -- dependent histone deacetylase, which is preserved in evolution from bacteria to humans.[@b19-dddt-11-1567] In human, seven different types of sirtuin are present. SIRT-1 is a protein deacetylase present in the cytoplasm and nucleus of cell. SIRT-1 is widely studied for its effects in various metabolic disorders. SIRT-1 utilizes oxidized NAD as a cofactor and is negatively regulated either by nicotinamide adenine dinucleotide or its deacetylation product nicotinamide.[@b20-dddt-11-1567] SIRT-1 deacetylates various substances, including uncoupling protein 2 (UCP-2) and peroxisome proliferator activated receptor gamma co-activator 1α (PGC-1α). SIRT-1 also exhibits control over metabolic tissues such as skeletal muscles, liver and adipose tissues.[@b21-dddt-11-1567] The UCP2 is a specific uncoupling protein present in the inner membrane of brown adipocytes's mitochondria and acts as negative regulator of insulin secretion. However, PGC-1α is the main regulator of glucose production in the liver that controls the entire gluconeogenic pathway.[@b22-dddt-11-1567] Interestingly, SIRT-1 is prominently expressed in β-cells of pancreas. SIRT-1 regulates the insulin secretion and sensitizes the peripheral tissues to the action of insulin.[@b23-dddt-11-1567],[@b24-dddt-11-1567] SIRT-1 regulates the PPAR-γ expression and thereby controls the process of adipogenesis and fat storing in the adipose tissues.[@b25-dddt-11-1567] Additionally, SIRT-1 plays an important role in the differentiation of muscle cells and regulation of metabolism in the liver. Therefore, extensive involvement of SIRT-1 in the control and regulation of insulin action describes its significance as a therapeutic target in Type-II DM.

SIRT-1: overproduction of ATP
-----------------------------

SIRT-1 is located in the cytoplasm and nucleus of pancreatic β-cells. Moynihan et al observed that suppression of UCP-2 due to over expression of SIRT-1 in pancreatic β-cells of mice enhances the production of ATP.[@b26-dddt-11-1567] SIRT-1 increases the insulin secretion with some reduction in the glycolytic flux. The oxidative phosphorylation and suppression of mitochondrial UCP-2 uncoupling were proposed as the cause of elevated ATP levels. Whereas, Guarente and Kenyon[@b27-dddt-11-1567] observed that decreased SIRT-1 activity and elevated mitochondrial protein UCP-2 level causes significant reduction in the ATP production. PGC-1α is a transcriptional co-activator that favorably modulates the glucose-stimulated insulin secretion through the stimulation of activity of gluconeogenic genes and suppression of activity of glycolytic genes. The β-cells of pancreas secrete both SIRT-1 and PGC-1α in small quantities. Gerhart Hines et al[@b28-dddt-11-1567] reported that SIRT-1 causes activation of PGC-1α and exhibits inhibitory effect on glucose metabolism in liver. Sirtuin agonists enhance the metabolic efficiency through increased insulin secretion and/or improved insulin sensitivity.[@b29-dddt-11-1567],[@b30-dddt-11-1567] Sirtuin causes the extension of life span and improvement of metabolism in simple organisms. It suggests the role of sirtuin pathway as a therapeutic target in metabolic diseases. However, rigorous genetic tests that need to confirm the ability of sirtuin as modulator of metabolism are still awaited.

Protein tyrosine phosphatase 1B: a dynamic player in insulin resistance
-----------------------------------------------------------------------

Protein tyrosine phosphatase 1B (PTP1B), belongs to the family of PTP enzymes encoded by Ptpn1 gene. It is a ubiquitously expressed, monomeric enzyme having 435 amino acids with molecular weight of 50 kDa.[@b31-dddt-11-1567],[@b32-dddt-11-1567] Dephosphorylated PTP1B regulates the important cell signaling events during cell growth, differentiation and apoptosis.[@b32-dddt-11-1567] Structurally, the N-terminal domain of PTP1B consists of two aryl phosphate-binding sites namely a high-affinity catalytic site that contains the nucleophile cysteine residue and low-affinity non-catalytic site containing the Arg24 and Arg254 residues.[@b33-dddt-11-1567] Whereas, the C-terminal domain of PTP1B includes proline residues and the hydrophobic amino acid residues 400--435. These residues are responsible for locating PTP-1B at the cytoplasmic phase of the endoplasmic reticulum.[@b34-dddt-11-1567] In insulin signaling pathway, PTP1B dephosphorylates several substrates such as tyrosine residues 1,162 and 1,163, which causes subsequent termination of receptor tyrosine kinase cascade. The binding of insulin to the insulin receptor (IR) phosphorylates the IR subunit 1 and causes the down-regulation of insulin signaling pathway.[@b35-dddt-11-1567] Moreover, PTB1B controls the interaction between IRS~1~ and IRS~2,~ which modulates the hepatic insulin action and insulin sensitivity.[@b36-dddt-11-1567] Thus, PTB1B plays a vital role in the insulin resistance and it is one of the important therapeutic targets in Type-II DM.

PTP1B inhibitors
----------------

It is evident that decreased PTP1B activity is related to increased insulin activity, which has a protective effect in diabetes.[@b37-dddt-11-1567] The PTP1B is a negative regulator of insulin signaling. The ability of PTP1B inhibitors to prolong the actions of insulin denotes their potential in the management of Type-II DM.[@b38-dddt-11-1567] Ertiprotafib belongs to the class of compounds that potently inhibit the PTP1B activity and normalizes plasma glucose and insulin levels in genetically diabetic and/or obese animals in experimental models of Type-II DM.[@b39-dddt-11-1567] One of the synthetic trissulfotyrosyldodecapeptides inhibited the IR dephosphorylation and enhanced the insulin signaling in Chinese hamster ovary cells over expressing human IRs.[@b40-dddt-11-1567]

Sodium-glucose linked transporter (SGLT): role in glucose transport and regulation
----------------------------------------------------------------------------------

Type-II DM has complex and multifactorial pathophysiology. Decrease in insulin secretion by pancreatic β-cells due to development of insulin resistance is the hallmark of Type-II DM. The insulin resistance in liver, brain and muscle leads to increased glucagon secretion, lipolysis and increased absorption of glucose by nephrons. Glucose is a vital source of energy for carrying out various cellular and metabolic processes. Lipoidal nature of cell membrane restricts the entry of polar glucose to extracellular region. Glucose is transported via two types of glucose transporters namely glucose transporter (GLUT) transporter and sodium-glucose transporter (SGT). There are 14 different types of GLUT transporters and 7 types of SGT are characterized. The GLUT transporter protein is a 12 membrane-spanning helical structure having amino and carboxyl terminals that are exposed on the cytoplasmic side of the plasma membrane. GLUT facilitates passive transport of glucose according to concentration gradient. In contrast, sodium glucose co-transporter involves the active transfer of glucose across the cell membrane against concentration gradient at the use of energy. Among various types of SGLT, only SGLT-1 and SGLT-2 facilitate the reabsorption of glucose into the plasma. Thus, inhibition of this process is proposed to decrease the blood glucose level and promote glucosuria. The kidney plays an important role in the glucose homeostasis. In a healthy adult, about 180--190 g of glucose per day is filtered from the glomeruli.[@b41-dddt-11-1567] Out of this filtered glucose, about 95% is reabsorbed through SGLT and circulatory glucose levels are maintained.[@b42-dddt-11-1567] The up-regulation of SGLT-2 in Type-II DM causes increased transportation of glucose and subsequent hyperglycemia.

SGLT-2 inhibition: a prospect to amend our therapeutic strategy
---------------------------------------------------------------

It is well established that inhibition of glucose reabsorption from kidney tubules improves the glucose homeostasis.[@b43-dddt-11-1567] Recently, SGLT-2 inhibitors demonstrated their effect on glycemic control in animal models of diabetes as well as Type-II DM patients.[@b44-dddt-11-1567] Clinical evidence for dual inhibition of SGLT-1 and SGLT-2 is available.[@b45-dddt-11-1567] SGLT-1 is the chief intestinal glucose transporter that reabsorbs about 10% of total renal glucose.[@b46-dddt-11-1567] Functional deficit of SGLT-1 leads to glucose malabsorption, which is exhibited by gastrointestinal symptoms.[@b47-dddt-11-1567] As SGLT-1 inhibition is associated with glucose malabsorption, selective SGLT-2 inhibitors were developed to avoid the SGLT-1-induced malabsorption state. SGLT-2 inhibitor decreases renal glucose reabsorption, increases urinary glucose excretion, improves the peripheral insulin sensitivity and enhances pancreatic β-cell function to maintain blood glucose levels.[@b48-dddt-11-1567],[@b49-dddt-11-1567]

Besides control of blood glucose level, SGLT-2 inhibitors also reduce blood pressure, body weight and lower the risk of hypoglycemia.[@b50-dddt-11-1567] The glucose-lowering effect of SGLT-2 inhibitors is comparable with the effect of metformin and dipeptidyl peptidase-4, (DPP-4) inhibitors when used as monotherapy. Thus, SGLT-2 inhibitors are suggested as alternative first-line therapeutic agents when metformin cannot be used. The first SGLT-2 inhibitor, canagliflozin was approved by the FDA in March 2013.[@b51-dddt-11-1567] Canagliflozin was studied in Type-II DM patients and compared clinically with standard antidiabetic drugs like metformin, glimepiride, sitagliptin, pioglitazone, etc. In phase III trial, canagliflozin at the dose of 100 mg and 300 mg showed the favorable effects in Type-II DM patients. Following the approval of canagliflozin, another SGLT-2 inhibitor, dapagliflozin is approved by the FDA for use in adults with Type-II DM in January 2014.[@b52-dddt-11-1567] The clinical efficacy and safety of the dapagliflozin as a SGLT-2 inhibitor were extensively studied using 14 clinical trials and evidence is widely documented.[@b53-dddt-11-1567]--[@b55-dddt-11-1567] Similarly, other molecules such as ipragliflozin and ertugliflozin are in development pipeline and currently at phase III trials.[@b56-dddt-11-1567]

GSK-3: constructive treats
--------------------------

Glycogen synthase, is a rate limiting enzyme involved in glycogen biosynthesis. GSK-3 was identified in the late 1970s, and possesses an ability to phosphorylate the glycogen synthase.[@b57-dddt-11-1567],[@b58-dddt-11-1567] The GSK-3 is conserved signaling molecule that belongs to serine/threonine kinases. It has an important role in diverse biological processes. It was observed that abnormal GSK-3 activity is associated with multiple human pathologies such as diabetes, psychiatric diseases, neurode-generative and inflammatory diseases.[@b59-dddt-11-1567] This observation laid down the foundation of hypothesis that GSK-3 inhibition has therapeutic benefits in various ailments. It has directed the research toward the discovery and design of selective GSK-3 inhibitors. The reported GSK-3 inhibitors include small molecules isolated from natural and marine sources or obtained from chemical synthesis. These inhibitors may act through multiple mechanisms, including competitive or non-competitive inhibition of ATP. Academic and industrial efforts have been made toward the discovery and development of novel GSK-3 inhibitors.[@b60-dddt-11-1567] Several chemical families with great structural diversity are reported to emerge as GSK-3 inhibitors. The number of small molecule GSK-3 inhibitors is on continuous rise and most of these inhibitors are in the early discovery phase.

Phosphatidylinositol 3-kinase/Akt
---------------------------------

Phosphatidylinositol 3-kinase (PI3K) and its downstream effector, serine-threonine protein kinase (Akt) are chief signaling enzymes implicated in cell survival and metabolic control.[@b61-dddt-11-1567],[@b62-dddt-11-1567] The phosphorylation of downstream apoptotic molecules such as BAX, Bcl-2-associated death promoter (BAD) and GSK-3β by PI3K/Akt elicit potent anti-apoptotic effect. The PI3K/Akt pathway is responsible for insulin-mediated glucose metabolism as well as protein synthesis and inactivation of its downstream target GSK-3, which is crucial for glucose sensing and β-cell growth.[@b63-dddt-11-1567] Thus, GSK-3 β can be the possible target for β-cell protective agents.[@b64-dddt-11-1567] Wortmannin, an antagonist of PI3K through down-regulation of PI3K/Akt signaling, inhibited the cell proliferation and induced the apoptosis.[@b65-dddt-11-1567] Different mechanisms and biological targets involved in Type-II DM are presented as [Figure 1](#f1-dddt-11-1567){ref-type="fig"} and [Table 3](#t3-dddt-11-1567){ref-type="table"}.

Discontinued drugs
------------------

Diabetes is the 6th major cause of worldwide deaths.[@b66-dddt-11-1567] Alarming increase in the incidence of diabetes demands for successful therapies. American biopharmaceutical research organizations are engaged in the development of about 180 new medicines for diabetes and related conditions. Currently, about 200 clinical trials on diabetic patients are ongoing in USA. Promising leads from the development pipeline have shown a hope for the control of diabetes complications at an affordable cost. However, failure of drugs to demonstrate promising results in the clinical trials and incidences of market withdrawal have resulted in the decline in interest of major pharmaceutical companies in diabetes research. In between 2012 and 2013 and in 2014, \~22 and 14 antidiabetic drugs were discontinued from various phases of drug development. Details of these discontinued drugs are described in [Table 4](#t4-dddt-11-1567){ref-type="table"}. Piramal Life Sciences discontinued the development of three antidiabetic drugs namely, P-11187, P-1736--05 and P-7435 in 2014. The P-11187 is G-protein-coupled receptor 40 (GPCR40) agonist, which showed promising results in Type-II diabetes. It acts through the stimulation of glucose-induced insulin secretion.[@b67-dddt-11-1567] P-11187 was described as an oral, highly selective and potent partial agonist of human, rat and mouse GPCR40 with effective concentration 50 (EC~50~) value of 14.4, 2.53 and 4.25 nM, respectively.[@b68-dddt-11-1567] P-1736-50 was considered as a PPAR-γ activator, but in preclinical studies, it failed to demonstrate its efficacy and hence was discontinued from further research. Piramal Life Sciences also discontinued the development of diacylglycerol acyltransferase 1 inhibitor P-7435 due to business focus. Similarly, Takeda discontinued TAK-875 (Fasiglifam) due to its hepatotoxic potential in phase III clinical trial. The MK-0893 is another molecule discontinued from the development process by Merck due to safety issues. Glucokinase is a major enzyme that phosphorylates glucose into glucose-6-phosphate. It is essential for glycogenesis and plays an important role in the hepatic glucose clearance. In 2013, Takeda was developing TAK-329 as glucokinase activator, but due to unexpected reasons, Takeda discontinued the development of this drug. Glucagon-like peptide 1 (GLP-1) and GIP are produced in intestine. The active forms of GLP and GIP increase the insulin secretion and regulate the glucose homeostasis. Upon release, GLP and GIP are immediately inactivated by dipeptidyl peptidase-4 (DP4) hence they have very short half-life.[@b69-dddt-11-1567] Therefore, the discovery of DP4 inhibitors is a promising approach toward the development of novel anti-diabetic drugs. The SYR-472 was a highly selective, long active DP4 inhibitor from Takeda that was discontinued due to its high development cost. Recently, Takeda has discontinued the development of combined PPAR-γ/α activator, sipoglitazar in phase III.[@b70-dddt-11-1567] Various anti-diabetic drugs that are discontinued from further research or withdrawn from the market are described in [Table 4](#t4-dddt-11-1567){ref-type="table"}.

Conclusion
==========

Scientific studies encircling the diabetes and its complications are on continuous rise. The annual cost of diabetes to the USA health care system is \$100 billion. Despite the availability of numerous antidiabetic drugs, search for the novel leads that completely cure Type-II DM is an ongoing quest. The disease architecture in Type-II DM is so complicated that even magic bullets, which selectively target one protein, fail to restore the biological network to healthy state. The current research scenario highlighted the need for identification and exploration of therapeutic targets in Type-II DM. Successful modulation of these biological targets can result in the cure of diabetes and associated complications. The present review provides an overview of therapeutic targets and their role in Type-II DM. This information can be used to plan the therapeutic strategies for the management of Type-II DM.

Search strategy
---------------

We searched data bases like PubMed, Medline, Google Scholar, Science Direct, Gene cards and DisGenNET along with proceedings available on websites of the American Diabetes Association and European Association for the Study of Diabetes. Full text articles published between 1980 and 2016 and written in English are included in present review. Databases were searched with keywords like names of target, gene, discontinued drugs, drugs withdrawn from market and inhibitors in development.
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![Involvement of different mechanisms for Type-II diabetes with targets.\
**Abbreviations:** 11βHSD1, 11β-hydroxysteroid dehydrogenase type 1; AC, adenylyl cyclase; Accp, acyl carrier protein; AICAR, 5-aminoimidazole-4-carboxamide nucleotide; AMPc, cyclic AMP; AMPK, AMP-activated protein kinase; AMPK-P, phosphorylated AMP-activated protein kinase; CaMKK, calcium mediated mitogen protein kinase kinase; coA, coenzyme A; COX2, cyclooxygenase2; CPT, carnitine palmitoyltransferase; DAG, Di-acyl glycerol; DM, diabetes mellitus; DP4, dipeptidyl peptidase-4; DPP4, inhibitors of dipeptidyl peptidase 4; EPAC2, guanine nucleotide exchange factor; ERRα, estrogen-related receptor-α; FA, fatty acid; FAS, fatty acid synthetase; fcoA, fluoroacetyl coenzyme A; FXR, farnesoid X receptor; GFR, growth factor receptor; GIP, gastric inhibitory polypeptide/glucose-dependent insulinotropic peptide; GLP-1, glucagon-like peptide-1; GPCR40, G-protein-coupled receptor 40 family; GSK3, glycogen synthase kinase 3; HSL, hormone sensitive lipase; HSP, heat shock protein; IAPP, amylin, or islet amyloid polypeptide; IL1, interleukin 1; IRS, insulin receptor substrate; LK, β 1 tumour suppressor kinase; LYN, belongs to Src family of protein tyrosin kinase; MCD, malonyl-CoA decarboxylase; mTOR, mammalian target of rapamycin; NAD, nicotinamide adenine dinucleotide; NF-κB, nuclear factor NF-kappa B; P, phosphorylation; P70rsk, p70 ribosomal S6 kinases; PHSL, P-hormone-sensitive lipase; PI3K, phosphoinositide 3-kinase; PKA, protein kinase A; PKC, protein kinase C; PP1, protein phosphatase 1; PPAR, peroxisome proliferator-activated receptor; PPAR-γ, peroxisome proliferator-activated receptor; PTP-1β, protein tyrosine phosphatase 1β; RXR, retinoid X receptor; SGT, sodium glucose transporter; SREBP, sterol regulatory element-binding proteins; TNFα, tumor necrosis factor alpha; UKPDS, United Kingdom Prospective Diabetes Study; VLDL, very low density lipoprotein.](dddt-11-1567Fig1){#f1-dddt-11-1567}
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Classification of diabetic therapeutic targets according to molecular group and signaling molecules

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Signal transduction and molecular mechanism   Targets                                                                                                                               Genes                   Subcellular locations                                                                                                          Biological process                                                                                                                       Associated drug(s)                                                                      Related disease(s) with this gene                                                                                                                                                                                                                           Associated pathways
  --------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------
  G protein-coupled receptor                    Glucagon-like peptide 1 receptor, gastric inhibitory polypeptide receptor and bile acid sequestrate                                   GLP1R, GIPR GPBAR1      Plasma membrane, extracellular, endoplasmic reticulum, nucleus                                                                 GLP1R, GIPR GPBAR1 stimulates the adenylyl cyclase pathway results in increased insulin synthesis and release                            GLP1R; exenatide liraglutide lixisenatide albiglutide dulaglutide\                      Hypertension, diabetes mellitus, neoplasms, obesity, pancreatic neoplasms, metabolic syndrome X, Cushing syndrome, colitis, carcinoma                                                                                                                       a\) Signaling by GPCR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      GPBAR1; betulinic acid                                                                                                                                                                                                                                                                                                                              b) Integration of energy metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Peptide ligand-binding receptors metabolism.[@b71-dddt-11-1567]

  G protein-coupled receptor                    Free fatty acid receptor or GPCR40, G protein-coupled receptor 119 and 39                                                             FFAR1 GPR119 GPR39      Nucleus, plasma membrane, peroxisome                                                                                           Protein metabolism                                                                                                                       FFAR1; Palmitic acid, oleic acid, linoleic acid.\                                       Diabetes mellitus obesity, glucagonoma, organ neoplasms, insulinoma, gastrinoma, fatty liver, metabolic disease                                                                                                                                             a\) Signaling by GPCR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      GPR119; oleoylglycerol anandamide                                                                                                                                                                                                                                                                                                                   b) Peptide ligand-binding receptors\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Incretin synthesis, secretion, and inactivation\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Integration of energy metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          e) Gastrin-CREB signalling pathway via PKC and MAPK

  Tyrosine kinase                               Insulin receptors                                                                                                                     INSR                    Plasma membrane, cytosol, endosome, extracellular, endoplasmic reticulum, mitochondria, nucleus                                Phosphorylation of receptor substrates Glucose homeostasis                                                                               Insulins\                                                                               Diabetes mellitus, Donohue syndrome, Rabson-Mendenhall syndrome, hyperinsulinism, diabetic neuropathies, glucose intolerance, Lewy body disease, proteinuria                                                                                                a\) GPCR pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Sulfonylureas\                                                                                                                                                                                                                                                                                                                                    b) Insulin receptor signaling cascade\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Meglitinides                                                                                                                                                                                                                                                                                                                                      c) Translation insulin regulation\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Nanog in mammalian ESC pluripotency

  Dehydrogenase                                 11β-hydroxysteroid dehydrogenase type 1                                                                                               HSD11B1                 Endoplasmic reticulum, nucleus, cytosol, peroxisome                                                                            Increase intracellular cortisol by 11β-hydroxysteroid dehydrogenase type 1 and activation of glucocorticoid receptor signaling pathway   BVT-14225 BVT-2733 Pyridyl sulfonamide                                                  Obesity hypertension, cortisone reductase deficiency, dermatitis, diabetes mellitus, Type-II                                                                                                                                                                a\) Metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          b) Steroid hormone biosynthesis\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Prostaglandin synthesis[@b72-dddt-11-1567]

  Oxidoreductase                                Cytochrome P450 family 3, subfamily A, polypeptide 4                                                                                  CYP3A4                  Endoplasmic reticulum, extracellular, cytosol, Golgi apparatus, nucleus, plasma membrane, cytoskeleton                         Metabolism                                                                                                                               Ritonavir                                                                               Breast neoplasm, prostatic neoplasm, osteosarcoma, hepatitis, torsades de pointes, diabetes mellitus, kidney failure, anxiety                                                                                                                               a\) Biological oxidations\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          b) Chemical carcinogenesis\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Cytochrome P450 -- arranged by substrate type

  Growth factor                                 Fibroblast growth factor 21                                                                                                           FGF21                   Extracellular, cytosol, mitochondria, nucleus, peroxisome                                                                      Effects on normalizing glucose, lipid, and energy homeostasis                                                                            --                                                                                      Obesity, fatty liver, diabetes mellitus, anorexia, ketosis. hypertension, stress, metabolic syndrome x, metabolic disease,\                                                                                                                                 a\) Apoptotic pathways in synovial fibroblasts\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              lipodystrophy, liver neoplasm                                                                                                                                                                                                                               b) GPCR pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) TGF-β pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) ERK signaling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          e) CREB pathway

  Glucose co-transporter                        Sodium--glucose co-transporter-2                                                                                                      SLC5A2                  Plasma membrane, cytosol                                                                                                       1\) Insulin-mediated glucose uptake in muscle and adipose tissue.\                                                                       Canagliflozin, dapagliflozin, remogliflozin, empagliflozin, sergliflozin (inhibitors)   hypertension diabetes mellitus, Type-II aminoaciduria glucosuria                                                                                                                                                                                            a\) Transmembrane transport of small molecules\
                                                                                                                                                                                                                                                                                                                                             2) GLUT1 mediates insulin-independent glucose transport                                                                                                                                                                                                                                                                                                                                                                                                                                      b) Metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Hexose transport

  Transcription factor                          Peroxisome proliferator-activated receptor gamma                                                                                      PPARG                   Extracellular, endoplasmic reticulum, peroxisome, nucleus, cytoskeleton                                                        On activation, they induce peroxisome proliferation and lead to metabolism of dietary fats                                               Aleglitazar, muraglitazar, tesaglitazar                                                 Inflammation hypertension, diabetes mellitus,\                                                                                                                                                                                                              a\) Nuclear receptor transcription pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              obesity, acute lung injury, acute kidney injury                                                                                                                                                                                                             b) Metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Fatty acid, triacylglycerol, and ketone body metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Pathways in cancer.[@b73-dddt-11-1567]

  Transcription factor                          Nuclear factor of kappa light polypeptide gene enhancer in B-cells, single transducer and activation of transcription 4, RANK1        NFkB1 STAT4 TNFRSF11A   Nucleus, cytosol, plasma membrane, endoplasmic reticulum, peroxisome                                                           Regulation of cytokine production, proliferation                                                                                         Curcumin, anethol, ursolic acid, capsaicin                                              Adenocarcinoma, colonic neoplasms, diabetes mellitus, obesity, liver cirrhosis, kidney failure, brain ischemia, liver diseases, hyperoxaluria, ovarian cysts, fatty liver, cerebral hemorrhage, breast neoplasms, autoimmune disease                        a\) TWEAK pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          b) 4--1BB pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) RANK signaling in Osteoclasts\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Cytosolic sensors of pathogen-associated DNA CNTF signaling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          e) GPCR pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          f) TGF-β pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          g) IL12-mediated signaling events

  Transcription factor                          Estrogen-related receptor-α                                                                                                           ESRRA                   Nucleus, mitochondria, peroxisome                                                                                              Metabolism                                                                                                                               Cyclohexamethylaminem, 5,7-dihydroxy-4 methoxyisoflavone                                Breast neoplasm, metabolic disease, diabetes mellitus, carcinoma, adenocarcinoma, neoplasm                                                                                                                                                                  a\) Fatty acid, triacylglycerol, and ketone body metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          b) Metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Gene expression\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Nuclear receptor transcription pathway

  Serine/threonine protein kinase               AMPK mechanistic targets of rapamycin                                                                                                 PRKAB1 MTOR             Nucleus, extracellular, cytosol, endoplasmic reticulum                                                                         Anabolism, catabolism, metabolism                                                                                                        Metformin, phenformin, acadesine                                                        Disease progression, stomach neoplasms, colonic neoplasms, diabetes mellitus, multiple myeloma, neurotoxicity, hepatocellular carcinoma, renal carcinoma, ovarian neoplasm                                                                                  a\) Insulin receptor signalling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          b) Signaling by GPCR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) ERK Signaling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) PI-3K cascade\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          e) Signaling by FGFR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          f) mTOR Pathway

  Ligase                                        Acetyl CoA, carboxylase α, Acetyl CoA, Carboxylase β                                                                                  ACACA ACACB             Cytosol, mitochondrion chloroplast, nucleus, peroxisome                                                                        Skeletal muscle fatty acid oxidation                                                                                                     --                                                                                      Carcinoma, fatty liver, insulin resistance, breast neoplasm, malignant neoplasm, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia                                                                                                                 a\) Defective BTD causes biotidinase deficiency\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          b) Regulation of cholesterol biosynthesis by SREBP\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          c) Fatty acid metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Metabolism

  Interleukin receptor                          Interleukin 12, interleukin 1, interleukin 18                                                                                         IL12B\                  Extracellular, cytosol, mitochondria                                                                                           Cytokine-mediated signaling pathway                                                                                                      IL-12(P40)2\                                                                            Multiple sclerosis, liver cirrhosis, hypothermia, reperfusion injury, glioma, asthma, diabetes mellitus, skin diseases, hypersensitivity, brain ischemia, pneumonia                                                                                         a\) PEDF-induced signaling\
                                                                                                                                                                                      IL1R1\                                                                                                                                                                                                                                                                                          DIAGRAM\                                                                                                                                                                                                                                                                                                                                            b) TGF-β pathway\
                                                                                                                                                                                      IL18                                                                                                                                                                                                                                                                                            EPIC-InterActs                                                                                                                                                                                                                                                                                                                                      c) Allograft rejection Toll-like receptor signaling pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          d) Akt signaling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          e) PEDF-induced signaling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          f) ERK signaling.[@b74-dddt-11-1567]

  Kinase and transferase                        Glycogen synthase kinase 3-β, Phosphatidylinositol-4,5-Bisphosphate 3 kinase, catalytic subunit-α, AKT1, Glucokinase (Hexokinase 4)   GSK3B\                  Plasma membrane, endoplasmic reticulum, extracellular, Golgi apparatus, nucleus, peroxisome, cytoskeleton, vacuole, endosome   Cellular response to stress, signal transduction, hemostasis, signal transduction via activation of PIK3 pathway                         CHIR, SB216763, TWS119, Eplerenone                                                      Alzheimer's disease, schizophrenia, bipolar disorder, prostatic neoplasm, depressive disorder, myocardial infarction, muscular atrophy, kidney injury, heart failure, arthritis, Parkinson disease, carcinoma, polycystic ovary syndrome, liver cirrhosis   a\) Signaling by FGFR\
                                                                                                                                                                                      PIK3CA\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             b) PI-3K cascade\
                                                                                                                                                                                      AKT1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               c) Translation Insulin regulation of translation\
                                                                                                                                                                                      GCK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 d) Development HGF signaling pathway\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          e) Insulin receptor signalling cascade\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          f) Signaling by Interleukins\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          g) Apoptotic pathways\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          h) Regulation of β-cell development\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          i) Metabolism\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          j) Activation of cAMP-Dependent PKA
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** '--' indicates growth factor does not have associated drug(s).

**Abbreviations:** BTD, biotidinase deficiency; cAMP: Cyclic adenosine monophosphate; ERK, extracellular signal--regulated kinase; FGFR, fibroblast growth factor receptors; GLUT1, glucose transporter 1; GPCR, G-protein-coupled receptor; HGF, Hepatocyte growth factor; PI-3K, Phosphoinositide 3-kinase; PEDF, pigment epithelium-derived factor; TGF-Beta, transforming growth factor β; TWEAK, TNF-related weak inducer of apoptosis; RANK, receptor activator of nuclear factor kappa-B.

###### 

Classification of diabetic therapeutic targets according to molecular mechanism

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Targets                                        Gene     Subcellular locations                                                                                                   Molecular function                            Biological process                                                                         Associated drug(s)                        Related disease(s) with this gene                                                                                                                                   Associated pathways                                                      Gene that shares disease with this gene
  ---------------------------------------------- -------- ----------------------------------------------------------------------------------------------------------------------- --------------------------------------------- ------------------------------------------------------------------------------------------ ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------ -----------------------------------------
  Islet amyloid polypeptide                      IAPP     Extracellular, endoplasmic reticulum, nucleus, plasma membrane                                                          Signaling molecule, signal transduction       Aggregation of amylin in insoluble amyloid fibrils and corresponds to insulin resistance   Pramlintide exenatide amylinamide         Diabetes mellitus, amyloidosis, hypertension, stomach ulcer, primary malignant, neoplasm                                                                            1\) Signaling by GPCR\                                                   TP53\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) PEDF induced signaling\                                               TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) ERK signaling\                                                        VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) Akt signaling                                                         BCL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  INS

  ATP-sensitive potassium channel                KCNJ11   Extracellular, endoplasmic reticulum, nucleus, plasma membrane, cytoskeleton                                            Cation channel                                Cation transport                                                                           Repaglinide, Nateglinide, Sulfonylurea    Diabetes mellitus, seizures, neonatal diabetes mellitus, insulin resistance, nesidioblastosis, hypertension, parkinsonian disorders, sciatic neuropathy, obesity    1\) Type-II diabetes mellitus\                                           INS-IGF2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Integration of energy metabolism\                                     IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Inwardly rectifying K+ channels\                                      VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) Metabolism                                                            IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ACE\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  APOE\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  INS-IGF2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PPARG\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MTHFR

  Heat shock protein                             HSPD1    Plasma membrane, cytosol, endosome, extracellular, endoplasmic reticulum, mitochondria, nucleus, chloroplast, vacuole   Chaperone                                     Protein metabolism                                                                         6-podoacetamido, subrem, fleroscinse      Endotoxemia, HIV infection, adenocarcinoma, acute coronary syndrome, cardiomyopathy, infarction                                                                     1\) Biosynthesis of the N-glycan precursor\                              TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) SIDS susceptibility pathways\                                         IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Legionellosis Validated targets of C-MYC transcriptional activation   IL10\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL1B\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL1A\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IFNG\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MMP9\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TLR4\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  CCL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  CXL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PTGS2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  CXCL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL1RN

  Insulin sensitizer                             INS      Plasma membrane, cytosol, endosome, extracellular, endoplasmic reticulum, mitochondria, nucleus, chloroplast, vacuole   Signaling molecule                            Protein metabolism                                                                         Metformin sulfonylureas cholesterol       Diabetes, Alzheimer's disease, obesity, polycystic ovary syndrome, hyperinsulinism, hypertension, glucose intolerance                                               1\) I nsulin receptor signalling cascade\                                INS-IGF2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Translation insulin regulation of translation\                        IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Regulation of β-cell development\                                     TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) Ras signaling pathway                                                 TP53\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IGF1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL1B\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TGFB1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ACE\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  BCL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  APOE

  Microsomal triglyceride transfer protein       MTTP     Endoplasmic reticulum, extracellular, cytosol, Golgi apparatus, nucleus, plasma membrane, cytoskeleton                  Other transporter, transfer/carrier protein   Lipid metabolism and other transport                                                       CP-346086                                 Abetalipoproteinemia, fatty liver, abdominal obesity, hyperlipidemias, leukemia, cardiovascular disease                                                             1\) Lipoprotein metabolism\                                              TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Metabolism\                                                           IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Statin pathway\                                                       TP53\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) Fat digestion and absorption                                          INS-IGF2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  INS\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MTHFR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL1B\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL10

  Protein tyrosine phosphatase1                  PTP1B    Endoplasmic reticulum, cytosol, nucleus, cytoskeleton, plasma membrane, endosome                                        --                                            Leptin and insulin signaling pathways                                                      BVT948 TCS401 Alexidine dihydrochloride   Obesity, insulin resistance, insulin sensitivity                                                                                                                    --                                                                       --

  Carbonyl reductase1                            CBR1     Cytosol, nucleus, endoplasmic reticulum, mitochondria                                                                   Reductase                                     --                                                                                         --                                        Pulmonary hypertension, breast neoplasm, pulmonary venocclusive disease, hyperandrogenism, pulmonary hypertension, reperfusion injury, diabetes mellitus, Type-II   1\) Metabolism\                                                          VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Arachidonic acid metabolism\                                          TGFB1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Chemical carcinogenesis\                                              TNF1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) Doxorubicin pathway                                                   MMP9\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TP53\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PPARG\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  HIF1A\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MTHFR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PTGS2

  Alpha glucosidase                              GAA      Plasma membrane, cytosol, endosome, extracellular, endoplasmic reticulum, mitochondria, nucleus                         Hydrolase                                     --                                                                                         Acabose, miglitol, voglibose              Glycogen storage, left ventricular hypertrophy, cardiomyopathy, ventricular dysfunctioning, ataxia, neurodegenerative disease, diabetes mellitus, heart disease     1\) Metabolism\                                                          TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Notch-mediated HES/HEY network Development\                           IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) VEGF signaling via VEGFR2 -- generic cascades Glucuronidation         INS\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  INS-IGF2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ACE\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  AR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL1B\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IGF1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TP53\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  APOE\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIK3CA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL10

  Vascular endothelial growth factor B           VEGFB    Extracellular, mitochondria, nucleus                                                                                    Signling molecule                             Hemostasis                                                                                 --                                        Retinal vein occlusion, brain injury, atherosclerosis, hypertrophy, inflammation, tumor progression                                                                 1\) Apoptotic pathways\                                                  VEGFA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Synovial Fibroblasts\                                                 IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) GPCR pathway\                                                         TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) TGF-β pathway\                                                        MMP9\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         5) ERK signaling\                                                        PTGST2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         6) CREB pathway                                                          IGF1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MMP2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PPARG\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  CCL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TIMP1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  THBS1

  Protein tyrosine phosphatase receptor type F   PTPRF    Plasma membrane, endoplasmic reticulum, extracellular, golgi apparatus, nucleus, peroxisome                             Hydrolase Phosphatase                                                                                                                    --                                        Stomach neoplasm, obesity, acromegaly, pheochromocytoma, breast carcinoma, melanoma, carcinoma, amastia                                                             1\) PAK pathway\                                                         TP53\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Insulin signaling\                                                    MYC\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Translation insulin regulation of translation                         EGF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  EGFR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ESR1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IGF1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IL6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIK3CA\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  BCL2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  STAT4

  Signal-regulatory protein-α                    SIRPA    Plasma membrane, endoplasmic reticulum, extracellular, nucleus, peroxisome, cytoskeleton                                Signaling molecule                            Hemostasis                                                                                 --                                        Schizophrenia, brain neoplasms, carcinoma, precancerous conditions, autoimmune diseases                                                                             1\) Cell junction organization\                                          TNF\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         2) Hemostasis\                                                           SR1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         3) Cardiac progenitor differentiation\                                   CDKN2A\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         4) Cell surface interactions at the vascular wall\                       PTGS2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         5) Osteoclast differentiation                                            L10\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  FNG
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Distribution of therapeutic targets of diabetes mellitus

  Molecular function           No of targets   Biological process     No of targets
  ---------------------------- --------------- ---------------------- ---------------
  Tyrosine kinase              1               Phosphorylation        1
  Dehydrogenase                1               Lipid metabolism       1
  Growth factor                1               Homeostasis            2
  Transport                    2               Insulin resistance     2
  Serine/threonine kinase      2               Transport and uptake   2
  Ligase                       2               Fatty acid oxidation   2
  Transfer carrier protein     2               Insulin release        3
  Oxidoreductase               2               Signal transduction    4
  Signaling molecule           3               Protein metabolism     5
  Interleukin receptor         3               Cytokine mediated      5
  Transcription factor         4               Other metabolism       5
  Hydrolase and protease       4                                      
  G-protein-coupled receptor   5                                      
  Kinase/Transferase           7                                      

###### 

Discontinued anti-diabetic drugs

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Compound                   Company                        Mechanism                                       Status (phase) at discontinuation   Date of discontinuation   Reason for discontinuation                       Notes                                                                                                                                                                  References
  -------------------------- ------------------------------ ----------------------------------------------- ----------------------------------- ------------------------- ------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------
  P-11187                    Piramal                        GPCR40 agonist                                  Phase I                             --                        Business focus                                   Highly selective, potent and orally active partial agonist of free fatty acid receptor 1 (GPCR40). Act through potentiation of glucose-stimulated insulin secretion    [@b68-dddt-11-1567]

  TAK-875                    Takeda                         GPCR40 agonist                                  Phase III                           27 Dec 2013               Hepatotoxicity                                   GPCR40 agonist having potential to cause liver injury                                                                                                                  

  P-7435                     Piramal                        DGAT-1 inhibitor                                Phase I                             --                        Business focus                                   Diacylglycerol acyltransferase 1 1) inhibitor. Potential to treat dyslipidemia and elevated glycemia in Type-II diabetes                                               [@b75-dddt-11-1567]

  P-7436                     Piramal                        Unknown                                         Preclinical                                                   Business focus                                   Initially designated as PPAR-γ activator but it failed to demonstrate this activity in preclinical studies                                                             

  NN1954 and NN1956          Novo Nordisk                   Oral insulin (to supply baseline insulin)       Phase I                             --                        Not disclosed                                    Long-acting insulin analogs delivered by oral tablets by so-called gastrointestinal permeation enhancement technology                                                  [@b68-dddt-11-1567]

  MK-0893                    Merck                          Glucagon receptor antagonist                    Phase II                            --                        Unexpected toxicity                              Demonstrated toxicity in clinical studies like increased levels of LDL & transaminase, elevated blood pressure and body weight                                         

  BMS-788 (XL-652)           BMS (Exelixis)                 Liver X Receptor (LXR) partial agonist          Phase I                             03 Jan 2014               Not disclosed                                    LXR is a novel target for impacting cardiovascular and metabolic disorders acting through cholesterol transport. BMS-788 is a small-molecule agonist of LXR            [@b68-dddt-11-1567]

  Betatrophin                Janssen                        β-cell trophin                                  Preclinical                         --                        Not disclosed                                    Betatrophin has role in the growth of pancreatic β-cells                                                                                                               

  LY-2382770                 Eli Lilly                      TGF-β mAb                                       Phase II                            21 Apr 2014               Not disclosed                                    Demonstrated nephroprotective effect in both Type-1 and Type-II diabetic subjects                                                                                      [@b68-dddt-11-1567]

  DiaPep227 (AVE-0277)       Hyperion                       Heat shock protein 60 (Hsp60)-derived peptide   Phase III                           --                        Data integrity                                   Effective in the prevention and treatment of Type-1 diabetes and autoimmune Type-II diabetes                                                                           

  AJD-101                    Ajinomoto/Daiichi Sanko        Insulin secretagogue                            Phase II                            02 Dec 2008               Unspecified                                      Stimulates insulin independent glucose uptake through the activation of insulin signaling pathway                                                                      

  KRP-104                    Kyorin/ActiveX                 Dipeptidyl peptidase 4 inhibitor                Phase II                            --                        Business focus                                   Acts through elevation of incretins.\                                                                                                                                  [@b68-dddt-11-1567]
                                                                                                                                                                                                                           Discontinued due to strategic decision of company                                                                                                                      

  NN9223                     Novo Nordisk                   GLP-1 agonist                                   Phase II                            21 Jun 2012               Dropped in favor of new candidate semaglutide    Acts through incretin pathways                                                                                                                                         

  PF-04991532                Pfizer                         Glucokinase activator                           Phase II                            10 May 2012               Unspecified                                      Hepatoselective glucokinase activator                                                                                                                                  [@b68-dddt-11-1567]

  PSN-821                    Astellas/OSI Pharmaceuticals   GPR119 agonist                                  Phase II                            04 Feb 2013               Unspecified                                      GPR119 receptors are G-protein coupled receptors that respond to fatty acids and stimulate insulin secretion                                                           [@b68-dddt-11-1567]

  Tagatose                   Spherix/Biospherics            Hexose (fructose epimer)                        Phase III                           --                        Failure to comply with regulatory requirements   It is a naturally occurring monosaccharide and functional sweetener                                                                                                    [@b75-dddt-11-1567]

  Tesaglitazar AZ-242        AZ                             PPAR-α and PPAR-γ agonist                       Phase III                           May 2006                  Adverse events                                   Demonstrated adverse effects like elevated serum creatinine and decreased glomerular filtration rate                                                                   

  Muraglitazar; BMS-298585   BMS                            PPAR-α and PPAR-γ agonist                       Phase III                           May 2006                  Adverse events                                   Showed cardiovascular side effect                                                                                                                                      

  CYT009-GhrQb               Cytos Biotechnology            Ghrelin                                         Phase II                            07 Nov 2006               Poor efficacy                                    CYT009-GhrQb is a vaccine                                                                                                                                              

  R-1438                     Hoffmann-La Roche              Unspecified                                     Phase II                            19 Oct 2006               Poor efficacy                                    --                                                                                                                                                                     

  Sipoglitazar (TAK-654)     Takeda                         Unspecified                                     Phase II                            12 Sep 2006               Poor efficacy and adversity                      --                                                                                                                                                                     

  Troglitazone               Daiichi Sankyo                 PPAR-α and PPAR-γ agonist                       --                                  21 March 2000             Hepatotoxicity                                   About 63 liver failure deaths are linked with the use of troglitazone                                                                                                  [@b76-dddt-11-1567]

  Pioglitazone               Takeda                         PPAR-γ agonist                                  --                                  2011 (France)\            Bladder cancer                                   Withdrawn from market due to increased risk of bladder cancer in patients taking Actos (pioglitazone) for a long time for the treatment of Type-II diabetes mellitus   [@b5-dddt-11-1567]
                                                                                                                                                2013 (India)                                                                                                                                                                                                                                      

  Phenformin                 Ciba-Geigy                     AMP-activated protein kinase                    --                                  October 1976              Lactic acidosis                                  Withdrawn from market due to potential to cause lactic acidosis                                                                                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** '--' indicates the date of discontinuation of drug is unclear.

**Abbreviations:** AMPK, AMP-activated protein kinase; GLP-1, glucagon-like peptide-1; GPCR-40, G-protein-coupled receptor 40; PPAR, peroxisome proliferator-activated receptor; LDL, low density lipoproteins; PPAR-γ, peroxisome proliferator-activated receptor.
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